PDA met ICH’s twelve eligibility criteria to gain recognition (PRESS RELEASE) BERLIN, 22-Nov-2019 — /EuropaWire/ — The Parenteral Drug Association (PDA) is proud to announce that its “ICH Q7 GMP for APIs” online training module is now endorsed by the … Read the full press release
Posted in Education, Germany, Healthcare, News, Pharma & Biotech, Science
Tagged active pharmaceutical ingredients, biopharmaceutical, GMPs, ICH, ICH Q7 GMP for APIs, ICH Recognised Training Programme, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, online training module, Parenteral Drug Association, PDA, pharmaceutical professionals, pharmaceuticals, Q7, training, training module, webinar
One week left to register for this event! (PRESS RELEASE) BERLIN, 28-May-2019 — /EuropaWire/ — The Parenteral Drug Association (PDA) is pleased to announce the speaker lineup for the 2019 PDA EU Advanced Therapy Medicinal Products: Cell and Gene Therapy … Read the full press release
Posted in France, Germany, Healthcare, Ireland, Italy, Lithuania, Media, Netherlands, News, Pharma & Biotech, Science
Tagged advanced therapy medicinal product, Alistair Gibb, ATMP, biopharmaceutical community, Cell, cell and gene therapies, Cell-Based Therapy Control Strategy, Control, GENE, GMP, Isabelle Bekeredjian-Ding, Manufacturing, medicine, Microbiological Quality Control in ATMP Manufacturing, Parenteral Drug Association, PDA, PDA EU ATMP Conference, pharmaceutical community, Romaldas Maciulaitis, The Paul-Ehrlich Institute, therapy, UK Medicines and Healthcare Products Regulatory Agency, Walter Morris
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
